← Back to all trials
Not Yet Recruiting
NCT07696962
Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease
Conditions: End Stage Renal Disease
Sex: All
Ages: 18 Years – 70 Years
Healthy volunteers: No
Phase: PHASE1
Enrollment: 4
Sponsor: Xeno Holdings (US), LLC dba ChoironeX
Location: Study Site 2 New York New York
Summary
The goal of this clinical trial is to learn if a GalKO Porcine Thymokidney can maintain renal function, without the need for dialysis, after transplantation into adult subjects with End Stage Renal Disease.
Eligibility Criteria
Inclusion Criteria
* ESRD receiving hemodialysis or peritoneal dialysis for ≥6 months
* Eligible for kidney transplantation per site criteria
* \
Source: ClinicalTrials.gov (NCT07696962). StuddyBuddy aggregates publicly available trial information.